By: IPP Bureau
Last updated : August 24, 2026 9:12 am
Delegate registrations are open for a high-level discussion on how genomics is transforming healthcare from reactive treatment to predictive, preventive and personalised care
Indian Pharma Post is bringing together leading executives and innovators from India’s genomics, diagnostics and precision medicine ecosystem for its upcoming E-Conference, “The Business of Genomics: Opportunities, Investments, and Innovation in India,” on August 26, 2026, from 3:00 PM to 4:30 PM IST.
The virtual conference will bring together senior leaders from genomics, diagnostics, biotechnology and precision healthcare to examine the commercial opportunities, investment landscape and innovations shaping India’s rapidly expanding genomics sector.
The speaker lineup includes Dr. Ramesh Hariharan, Chief Executive Officer, Strand Life Sciences; Mr. Anindya Chowdhury, Chief Business Officer, MedGenome Labs; Kapil Ravi, Founder Director, ComputeGenomics; Gaurav Jain, Chief Operating Officer, Redcliffe Labs; Dr. Debojyoti Dhar, Co-Founder & Director, Leucine Rich Bio; Hitesh Goswami, CEO and Co-Founder, 4baseCare; Harkaran Dhingra, Chief Executive Officer, DSS Takara Bio India. The discussion will be moderated by Rahul Koul, Editor, Indian Pharma Post.
Click here https://www.indianpharmapost.com/webinar/the-business-of-genomics-opportunities-investments-and-innovation-in-india-7 to register for the webinar.
The conference comes at a time when India’s genomics ecosystem is witnessing rapid growth, driven by advances in sequencing technologies, artificial intelligence, precision medicine, diagnostics and personalised healthcare. The Indian genomics market, valued at approximately US$2.5 billion in 2025, is projected to reach nearly US$9.5 billion by 2034, according to industry estimates.
The discussion will explore how genomics is moving healthcare from reactive treatment towards predictive, preventive and personalised care, while creating new opportunities across diagnostics, drug discovery, targeted therapies and digital health.
Key areas of discussion will include the affordability and scalability of genomic testing, integration of genomic testing into clinical practice, AI-powered genomics, genomic data infrastructure, genomics-driven drug discovery, India's genetic diversity, investment opportunities in genomics startups and the regulatory and ethical considerations surrounding genomic data.
The speakers will also discuss the challenges and opportunities involved in building a globally competitive genomics ecosystem in India and how collaborations between healthcare providers, diagnostics companies, technology firms, researchers and investors can accelerate adoption.
The E-Conference is aimed at genomics, biotech, diagnostics and pharmaceutical industry leaders, healthcare executives, startup founders, investors, researchers, clinicians, bioinformatics and AI professionals, pharmaceutical R&D teams, academicians and young life sciences professionals.
The programme will also include a live Q&A session, allowing participants to engage with the speakers on the opportunities and challenges shaping the next phase of India’s genomics industry.
Date: August 26, 2026
Time: 3:00 PM–4:30 PM IST
Format: Virtual | Registration required